Porton Pharma Solutions
Chongqing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A major CDMO providing end-to-end development and manufacturing services for small molecules and biologics.
CDMO Services
Technology Platform
An integrated service platform offering end-to-end process development, scale-up, and cGMP manufacturing for small molecule APIs and biologics.
Opportunities
Continued growth driven by global biopharma outsourcing trends and expansion into advanced modalities like cell and gene therapy.
Risk Factors
Geopolitical tensions affecting global supply chains and potential regulatory scrutiny on overseas manufacturing.
Competitive Landscape
A top-tier CDMO competing globally with firms like WuXi AppTec and Lonza, leveraging cost advantages and scale.